Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Comment by SPCEO1on Nov 29, 2021 4:04pm
145 Views
Post# 34177281

RE:RE:RE:RE:RE:I try to remind myself

RE:RE:RE:RE:RE:I try to remind myselfAnother factor leading to selling today could be someone facing an imminent margin call and selling TH to try to get ahead of that following Friday's market meltdown.

Wino115 wrote: There's probably still lots of shareholders who have peripheral holdings, showing either a loss or that it was up a decent amount just for the year, so why not well.  I can't say I'm helping as I put in below market offers and the desperate sellers hit my buy orders. 

I'm looking at this typical year end dump as a spring that will sprong Jan 2 or sooner!   There's been no news so if you know what's actually going on, that is actually either neutral or positive. The neutral is they stuck the level where they were -- either 1.5x or 2x -- and are now getting those final 6 patients lined up with that dose.  If no SAEs, they're ready for the 1b efficacy study.  That's not bad news, that's good news.   Onward and Upward!

retiredRIA wrote: I guess I am the only one taking advantage of this Black Monday sale of THTX!




<< Previous
Bullboard Posts
Next >>